NLS Pharmaceutics AG (NLSP)
NASDAQ: NLSP · Real-Time Price · USD
1.710
+0.094 (5.82%)
At close: May 19, 2025, 4:00 PM
1.640
-0.070 (-4.09%)
Pre-market: May 20, 2025, 9:07 AM EDT

NLS Pharmaceutics AG Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Net Income
-1.98-12.17-16.5-11.95-2.86
Upgrade
Depreciation & Amortization
00.010.010.01-
Upgrade
Other Amortization
--0.070.040.07
Upgrade
Stock-Based Compensation
0.130.160.02--
Upgrade
Provision & Write-off of Bad Debts
---0.08-
Upgrade
Other Operating Activities
-2.490.060.890.050.02
Upgrade
Change in Accounts Receivable
----0.02-0.01
Upgrade
Change in Accounts Payable
-0.122.260.64-2.271.5
Upgrade
Change in Other Net Operating Assets
0.2-0.010.99-0.880.56
Upgrade
Operating Cash Flow
-4.27-9.68-13.88-14.94-0.73
Upgrade
Capital Expenditures
-0---0.04-
Upgrade
Investing Cash Flow
-0---0.04-
Upgrade
Short-Term Debt Issued
-1.63-0.110.68
Upgrade
Long-Term Debt Issued
--1.53-0.51
Upgrade
Total Debt Issued
-1.631.530.111.19
Upgrade
Short-Term Debt Repaid
----0.78-
Upgrade
Long-Term Debt Repaid
---0.7-1.43-
Upgrade
Total Debt Repaid
---0.7-2.21-
Upgrade
Net Debt Issued (Repaid)
-1.630.83-2.11.19
Upgrade
Issuance of Common Stock
5.43-9.2415.7-
Upgrade
Other Financing Activities
-0.39-7.336.74-0.69
Upgrade
Financing Cash Flow
5.041.6317.420.340.5
Upgrade
Foreign Exchange Rate Adjustments
---0-0.020.1
Upgrade
Net Cash Flow
0.77-8.053.525.34-0.13
Upgrade
Free Cash Flow
-4.27-9.68-13.88-14.98-0.73
Upgrade
Free Cash Flow Per Share
-2.77-10.15-28.21-50.33-4.19
Upgrade
Cash Interest Paid
00.150.010.34-
Upgrade
Levered Free Cash Flow
-7.46-5-8.69-10.660.64
Upgrade
Unlevered Free Cash Flow
-7.37-4.9-8.69-10.660.71
Upgrade
Change in Net Working Capital
5.09-2.3-0.953.22-2.15
Upgrade
Updated Oct 18, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q